Dr Nicolas Poirier , CEO, Ose Immunotherapeutics 00:00:00

Share On Facebook Share On Twitter

OSE Immunotherapeutics (OSE) is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharmaceutical companies.

Recent Videos